An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin

2005 ◽  
Vol 23 (5) ◽  
pp. 437-443 ◽  
Author(s):  
H. Hirte ◽  
D. Stewart ◽  
R. Goel ◽  
E. Chouinard ◽  
S. Huan ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Phase I ◽  
Pharmacokinetic Study ◽  
Dose Escalation ◽  
Matrix Metalloproteinase Inhibitor ◽  
Metalloproteinase Inhibitor ◽  
The Matrix

A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors

2004 ◽  
Vol 55 (2) ◽  
pp. 136-142 ◽  
Author(s):  
André Planting ◽  
Ate van der Gaast ◽  
Patrick Schöffski ◽  
Michele Bartkowski ◽  
Coleta Verheij ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Matrix Metalloproteinase Inhibitor ◽  
Metalloproteinase Inhibitor ◽  
The Matrix ◽  
Pharmacologic Study

Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors

2001 ◽  
Vol 48 (4) ◽  
pp. 269-274 ◽  
Author(s):  
Elisabeth Heath ◽  
Seamus O'Reilly ◽  
Rachel Humphrey ◽  
Pavur Sundaresan ◽  
Ross Donehower ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Advanced Solid Tumors ◽  
Matrix Metalloproteinase Inhibitor ◽  
Metalloproteinase Inhibitor ◽  
The Matrix

scholarly journals Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566

2001 ◽  
Vol 12 (3) ◽  
pp. 389-395 ◽  
Author(s):  
C. Erlichman ◽  
A.A. Adjei ◽  
S.R. Alberts ◽  
J.A. Sloan ◽  
R.M. Goldberg ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Phase I ◽  
Phase I Study ◽  
Matrix Metalloproteinase Inhibitor ◽  
Metalloproteinase Inhibitor ◽  
The Matrix
Sign in / Sign up

Export Citation Format

Share Document